MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.

Oncotarget · 2014 · PMC4012720 · PMID 24658326

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

Notably, the SF188 cells showed quite significant inhibition of short- and long-term survival and proliferation, likely in large part due to TAM RTK inhibition as there is very little/no activation of cMet related signaling in this line.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.